A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL.
The file type is application/pdf.
Advances in Clinical Application of ctDNA Detection in NSCLC
2018
Journal of Cancer Treatment and Diagnosis
Preserved Fulltext
With high morbidity and mortality, lung cancer has become the leading cause of cancer-related death worldwide, of which 85% are non-small-cell lung cancer (NSCLC). Most patients present with advanced disease at diagnosis and 5-year survival rate is no more than 30% due to lack of appropriate screening and early detection. In spite of tissue samples, ctDNA (circulating tumor DNA) is also widely used for molecular profiling to guide the treatment of NSCLC for lots of advantages. This review
doi:10.29245/2578-2967/2018/2.1121
fatcat:u7uwjediw5dufof4gq3qzmizqm